The latest report by IMARC Group, titled “Vascular Stents Market Report by Product Type (Coronary Stents, Peripheral Vascular Stents, Evar Stent Grafts), Material (Metallic Stents, and Others), Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), End-User (Hospitals and Cardiac Centers, Ambulatory Surgical Centers), and Region 2024-2032“, The global vascular stents market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032
Factors Affecting the Growth of Vascular Stents Industry:
- Increasing Incidence of Cardiovascular Diseases
The primary driver behind the growth of the vascular stents market is the rising incidence of cardiovascular diseases (CVDs) worldwide. CVDs, which include conditions such as coronary artery disease and peripheral artery disease, continue to be a leading cause of morbidity and mortality globally. The aging population, sedentary lifestyles, and dietary habits contribute to the higher prevalence of CVDs. With a growing number of patients diagnosed with cardiovascular conditions, there is an increased demand for interventional cardiology procedures, including the placement of vascular stents. These stents help to open narrowed or blocked arteries, restoring blood flow and reducing the risk of complications. As a result, the vascular stent market is witnessing significant expansion to meet the escalating healthcare needs of the aging population and those at risk of CVDs.
- Advancements in Stent Technology:
Advancements in stent technology have revolutionized the vascular stents market. Manufacturers have been consistently innovating to improve the safety and efficacy of stents, leading to the development of drug-eluting stents (DES) and bioresorbable stents. DES, for instance, are coated with medications that help prevent restenosis, a common problem in which arteries narrow again after stent placement. Furthermore, bioresorbable stents are designed to gradually dissolve in the body, eliminating the need for a permanent implant. These innovations have enhanced patient outcomes, reduced complications, and led to shorter recovery times, making stent implantation a more attractive option for both patients and healthcare providers.
- Growing Aging Population:
The global demographic shift toward an aging population is another significant factor driving the vascular stents market. As individuals age, they are more prone to developing various cardiovascular conditions due to factors such as arterial aging and plaque buildup. This demographic trend has resulted in a higher demand for cardiovascular interventions, including the placement of vascular stents. Moreover, older adults often have multiple comorbidities, making them candidates for complex coronary and peripheral artery procedures, where stents play a crucial role in restoring and maintaining blood flow. The aging population increases the number of potential patients and also drives research and development efforts to create stents tailored to the specific needs of elderly individuals, further fueling market growth.
Competitive Landscape with Key Player:
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik Se & Co. Kg
- Braun Melsungen Ag
- Terumo Corporation
- Microport Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Vascular Concepts Limited
- C.R. Bard Inc.
- W.L. Gore and Associates Inc.
- Endologix, Inc.
- Lombard Medical
- Translumina Gmbh
- Jotec Gmbh
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/vascular-stents-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Coronary Stents
- Peripheral Vascular Stents
- Evar Stent Grafts
Coronary stents dominate the market due to the high prevalence of coronary artery disease and the widespread adoption of coronary stents as a standard intervention for restoring blood flow in coronary arteries, making it the dominant category in the stent market.
Breakup by Material:
- Metallic Stents
- Cobalt Chromium
- Platinum Chromium
- Nickel Titanium
- Stainless Steel
- Others
Metallic stents hold maximum number of shares due to their proven durability, flexibility, and effectiveness in maintaining vessel patency, making them the preferred choice for a wide range of cardiovascular interventions.
Breakup by Mode of Delivery:
- Balloon-Expandable Stents
- Self-Expanding Stents
Balloon-expandable stents represent the largest segment due to their precise and controlled deployment, which allows for effective treatment of narrowed or blocked arteries, making them a preferred choice for interventional procedures.
Breakup by End-User:
- Hospitals and Cardiac Centers
- Ambulatory Surgical Centers
Hospitals and cardiac centers dominate the market due to their central role in providing comprehensive cardiovascular care, including diagnosis, treatment, and surgical interventions, making them primary users of vascular stents.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the vascular stents market is attributed to its robust healthcare infrastructure, high prevalence of cardiovascular diseases, and substantial investments in medical research and innovation.
Global Vascular Stents Market Trends:
The vascular stents market is dynamic, with companies continually developing and launching new stent products. Regulatory approvals for these innovations are crucial in driving market growth. As new stents with improved features and efficacy gain regulatory clearance, they enter the market, offering more options to healthcare providers and patients. Additionally, technological advancements in imaging techniques, such as angiography and intravascular ultrasound (IVUS), are playing a significant role in the vascular stents market. These advanced imaging tools allow healthcare professionals to precisely diagnose and assess vascular conditions, helping them select the most appropriate stent type and placement strategy. This results in improved patient outcomes and drives the demand for vascular stents.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
